China NMPA Product Recall - Nano Acupoint Patch

Chongqing Yixintang Trading Co., Ltd. initiated a voluntary Level III recall of its nano acupoint patches (registration number: "渝食药监械（准）字2014第1260098号"), as publicly announced on October 22, 2020, by the National Medical Products Administration (NMPA). The primary reasons cited for this action were specific issues related to product labeling, alongside other unspecified factors, as reported by the company and confirmed by the Chongqing Municipal Drug Administration. This regulatory action is overseen by the NMPA and the Chongqing Municipal Food and Drug Administration, which previously published relevant information on June 29, 2017. A Level III recall signifies that exposure to the affected product is not expected to cause adverse health consequences. The company's required action involves systematically retrieving all identified affected batches of the nano acupoint patches from the market. Detailed information concerning specific product models, specifications, and batch numbers is available in the associated "Medical Device Recall Event Report Form." This proactive measure underscores the commitment to compliance with medical device regulations and maintaining product integrity.